Dr Jon Raby and Dr Lisbeth Jacobs have accused Brent Robinson of running a ‘spill and fill’ campaign.
The listed health company does not expect a material effect on 2024 earnings guidance.
The NZX-listed publican is set to delist later this year, if shareholders approve the sale of its business.
Gentailer touts 4.7GW pipeline of renewable energy development.
Chemicals group’s only female director has resigned.
Second-half catch-up a tall order as company reaffirms guidance.
The retailer is also testing the temperature of new markets.
CEO Michael Boggs says current half better already – with election, Rugby World Cup, and Christmas yet to unfold.
Macroeconomic environment continues to challenge equity capital raising and trading.
Global case sales rise 9%, while net profit lifts 3% to nearly $65m.